Monopar Therapeutics (MNPR) Shareholder's Equity (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Monopar Therapeutics | 466.82 Mn | 466.82 Mn | - | 137.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 137.83 Mn |
| Sep 30, 2025 | 141.56 Mn |
| Jun 30, 2025 | 52.20 Mn |
| Mar 31, 2025 | 53.59 Mn |
| Dec 31, 2024 | 55.04 Mn |
| Sep 30, 2024 | 4.95 Mn |
| Jun 30, 2024 | 6.09 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Dec 31, 2023 | 5.59 Mn |
| Sep 30, 2023 | 6.61 Mn |
| Jun 30, 2023 | 7.84 Mn |
| Mar 31, 2023 | 8.94 Mn |
| Dec 31, 2022 | 10.09 Mn |
| Sep 30, 2022 | 12.51 Mn |
| Jun 30, 2022 | 14.52 Mn |
| Mar 31, 2022 | 16.97 Mn |
| Dec 31, 2021 | 18.94 Mn |
| Sep 30, 2021 | 21.28 Mn |
| Jun 30, 2021 | 23.35 Mn |
| Mar 31, 2021 | 25.10 Mn |
| Dec 31, 2020 | 15.69 Mn |
| Sep 30, 2020 | 17.49 Mn |
| Jun 30, 2020 | 12.15 Mn |
| Mar 31, 2020 | 12.40 Mn |
| Dec 31, 2019 | 12.63 Mn |
| Sep 30, 2019 | 4.62 Mn |
| Jun 30, 2019 | 5.13 Mn |
| Mar 31, 2019 | 5.77 Mn |
| Dec 31, 2018 | 6.92 Mn |
| Sep 30, 2018 | 7.58 Mn |
| Jun 30, 2018 | 8.12 Mn |
| Mar 31, 2018 | 8.86 Mn |
| Dec 31, 2017 | 9.62 Mn |
| Dec 31, 2016 | 2.83 Mn |